Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Head and Neck Neoplasms × enfortumab vedotin × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Transitional Cell 14 Urinary Bladder Neoplasms 8 Ureteral Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasm Metastasis 2 Advanced Bladder Cancer 2 Urogenital Neoplasms 1 Urethral Neoplasms 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Peripheral Nervous System Diseases 1 Penile Squamous Cell Carcinoma (PSCC) 1 Muscle-invasive Bladder Cancer 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Metastatic Urothelial Cancer 1 Metastatic Castration-resistant Prostate Cancer 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

pembrolizumab 18 Radiotherapy 10 Cisplatin 10 Carboplatin 9 Cetuximab 8 Paclitaxel 7 Drug Therapy 4 Radiotherapy, Intensity-Modulated 3 Nivolumab 3 Docetaxel 3 toripalimab 2 tislelizumab 2 palbociclib 2 osimertinib 2 fludarabine 2 X-Rays 2 Surveys and Questionnaires 2 Standard of Care 2 Radiation 2 Pravastatin 2 Magnetic Resonance Spectroscopy 2 Ketoprofen 2 Fulvestrant 2 Fluorouracil 2 Equipment and Supplies 2 Cyclophosphamide 2 Chemoradiotherapy 2 Blood Specimen Collection 2 Afatinib 2 ulixertinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡